The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Lacosamide (NDC 70771-1682). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
NDC 70771-1682-1
Lacosamide Injection, USP 200 mg/20 mL (10 mg/mL); CV
For Intravenous Use Only
20 mL single-dose vial
Rx only
Vial Label (2e8b7789 C673 4f02 B73b Bd465c71c7f5 01)
NDC 70771-1682-6
Lacosamide Injection, USP 200 mg/20 mL (10 mg/mL); CV
For Intravenous Use Only
10 X 20 mL Single-dose vials
Rx only
Carton Label (2e8b7789 C673 4f02 B73b Bd465c71c7f5 02)
* Please review the disclaimer below.
